Description: Cryo-Cell International, Inc. is the world’s first private cord blood bank. More than 500,000 parents from 87 countries have entrusted Cryo-Cell International with their baby’s cord blood and cord tissue stem cells. In addition to its private bank, Cryo-Cell International has a public banking program in partnership with Duke University. Cryo-Cell’s public bank has provided cord blood for more than 600 transplantations and operates cord blood donation sites across the U.S in prominent hospitals such as Cedars–Sinai Hospital in Los Angeles and Baptist Hospital in Miami. Cryo-Cell’s facility is FDA registered, cGMP-/cGTP-compliant and licensed in all states requiring licensure. Besides being AABB accredited as a cord blood facility, Cryo-Cell was also the first U.S. (for private use only) cord blood bank to receive FACT accreditation for adhering to the most stringent cord blood quality standards set by any internationally recognized, independent accrediting organization. Cryo-Cell owns the exclusive rights to PrepaCyte-CB, the industry’s most advanced cord blood processing technology.
Home Page: www.cryo-cell.com
CCEL Technical Analysis
700 Brooker Creek Boulevard
Oldsmar,
FL
34677
United States
Phone:
813 749 2100
Officers
| Name | Title |
|---|---|
| Mr. David I. Portnoy | Chairman & Co-CEO |
| Mr. Mark L. Portnoy | Co-CEO & Director |
| Ms. Jill M. Taymans | CFO & VP of Fin. |
| Mr. Oleg Mikulinsky | Chief Information Officer |
| Dr. Joanne Kurtzberg M.D. | Medical Director and Member of Medical & Scientific Advisory Board |
Exchange: NYSE MKT
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Providers & Services |
| GIC Sub-Industry: | Health Care Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 29.125 |
| Price-to-Book MRQ: | 9.7236 |
| Price-to-Sales TTM: | 1.2029 |
| IPO Date: | 1997-01-21 |
| Fiscal Year End: | November |
| Full Time Employees: | 83 |